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Background: The use of secondary data in health care research has 
become a very important issue over the past few years. Data from 
the treatment context are being used for evaluation of medical data 
for external quality assurance, as well as to answer medical ques-
tions in the form of registers and research databases. Additionally, 
the establishment of electronic clinical systems like data warehouses 
provides new opportunities for the secondary use of clinical data. 
Because health data is among the most sensitive information about an 
individual, the data must be safeguarded from disclosure. Depending 
on type of data to be used and the purpose of research, legal require-
ments on secondary use of clinical data vary between countries. The 
US regulations Health Insurance Portability and Accountability Act 
(HIPAA), Health Information Technology for Economic and Clinical 
Health Act (HITECH) and the EU’s Directive 95/46/EC form the legal 
basis for medical research in the United States and the EU and are 
subject to be compared in this project.
Methods: It is of interest to investigate the legal requirements as 
outlined in US and European laws and regulations with the objective 
to identify potential similarities and differences. In order to explore 
the commonalities and differences, a model will be developed that 
contains all aspects that need to be considered prior to providing data 
for secondary uses. The criteria used in this comparison will include 
data privacy how the US and EU regard the secondary use of clinical 
data, which ethical issues are pertinent, and how identifiable and 
de-identified data can be shared.
Results: Some preliminary results include that the US and EU have 
significantly different legal structures for data protection and protect 
personal data differently. While the US approaches privacy by sector 
(i.e. financial and health care separately), the EU takes a more com-
prehensive general approach to privacy. Each European member state 
has its own data protection regulations that must meet the Directives 
requirements. This is accomplished by implementing Directive 95/46 
in their legal structure. In the United States, data protection is frag-
mented into different regulations and acts. While the EU requires 
unambiguous consent from the data subject prior to the collection, 
processing and use of data, HIPAA, the US healthcare privacy law, 
allows organizations to share data for research purposes without 
individual authorization. Both US and European data protection laws 
require that organizations de-identify data prior to disseminating 
it. This implicates that both the United States and the EU assume 
that anonymization protects privacy, which is subject to controversy.
Discussion: The current cursory review has shown a few differences; 
however, a much deeper analysis will be conducted. Indications show a 
much more comprehensive exploration should be conducted since the 
laws and regulations on data protection in the EU and United States are 
immense. Based on the current literature review, little past research has 
compared these complex regulations to this extent before. A comprehen-
sive review offers the potential to improve and facilitate joint research 
projects on health care issues between the EU and the United States.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
